425
TABLE OF CASES
A
aaiPharma v. Thompson, 296 F.3d 227 (4th Cir. 2002), 82
Abbott Laboratories v. Baxter International, 2002 U.S. Dist. LEXIS 5475
(N.D. Ill. 2002), 268, 269
Abbott Labs. v. Brennan, 952 F.2d 1346 (Fed. Cir. 1991), 308
Abbott Labs. v. Mylan Pharms., 2007 U.S. Dist. LEXIS 12839 (N.D. Ill.
2007), 306
Abbott Labs. v. Teva Pharms. USA, 432 F. Supp. 2d 408 (D. Del. 2006),
306, 309, 313, 330, 331, 333, 334, 335
Abbott Labs. v. Young, 920 F.2d 984 (D.C. Cir. 1990), 82
Abraham v. Intermountain Health Care, 461 F.3d 1249 (10th Cir. 2006),
383
Actavis/Warner Chilcott PLC, No. C-4414 (FTC 2013), 178, 199, 208
217, 218
Actos End Payor Antitrust Litig., In re, 2015 U.S. Dist. LEXIS 127748
2017), 279, 280, 281, 319
Addamax v. Open Software Foundation, 152 F.3d 48 (1st Cir. 1998), 244
Adderall XR Antitrust Litigation, In re, 754 F.3d 128 (2d Cir. 2014),
298, 299
ADT Sec. Sys. v. Guerra, 1997 WL 114784 (D. Conn. 1997), 311
Aggrenox Antitrust Litig., In re, 11 F. Supp. 3d 1342 (J.P.M.L. 2014),
130
Agnew v. NCAA, 683 F.3d 328 (7th Cir. 2012), 169, 242
Akorn/VersaPharm, No. C-4479 (FTC 2014), 203, 215
Alabama v. Blue Bird Body Co., 573 F.2d 309 (5th Cir. 1978), 139
Allen-Myland v. IBM, 33 F.3d 194 (3d Cir. 1994), 159
Allergan/Inamed, No. C-4156 (FTC 2006), 216, 217, 251
Allied Orthopedic Appliances v. Tyco Health Care, 592 F.3d 991 (9th
Cir. 2010), 341, 369
Amarel v. Connell, 102 F.3d 1494 (9th Cir. 1996), 314
Amgen/Immunex, No. C-4056 (FTC 2002) 175, 199, 218, 224, 225
426 Pharmaceutical Industry Antitrust Handbook
Amphastar Pharms., Inc., v. Momenta Pharms., Inc., 850 F.3d 52 (1st
Cir. 2017), 303
Andrews v. Bechtel Power, 780 F.2d 124 (1st Cir. 1985), 135
AndroGel Antitrust Litig., In re, 687 F. Supp. 2d 1371 (N.D. Ga. 2010),
253
AndroGel Antitrust Litig. (No. II), In re, 888 F. Supp. 2d 1336 (N.D Ga.
2010), 311
Andrx Pharms. v. Biovail Corp., 256 F.3d 799 (D.C. Cir. 2001), 111, 315
Andrx Pharms. v. Elan Corp., PLC, 421 F.3d 1227 (11th Cir. 2005), 310
Anheuser-Busch v. Abrams, 71 N.Y.2d 327 (N.Y. 1988), 122
Apotex, Inc. v. Shalala, 1999 WL 956686 (D.C. Cir. 1999), 90
Apotex, Inc. v. Thompson, 347 F.3d 1335 (Fed. Cir. 2003), 86
Applied Med. Res. Corp. v. Ethicon, 2006 U.S. Dist. LEXIS 12845 (C.D.
Cal. 2006), 379, 380, 381
Arizona v. Maricopa County Medical Society, 457 U.S. 332 (1982), 237
Arkansas Carpenters Health & Welfare Fund v. Bayer AG, 604 F.3d 98
(2d Cir. 2010), abrogated on other grounds by FTC v. Actavis, 570
U.S. 136 (2013), 309
Asacol Antitrust Litig., In re, 2016 U.S. Dist. LEXIS 94605 (D. Mass.
2016), 303
Asahi Glass Co. v. Pentech Pharms., 289 F. Supp. 2d 986 (N.D. Ill.
2003), 274
Asociacion de Farmacias Region de Arecibo, 127 F.T.C. 266 (1999), 260
Aspen Skiing Co. v. Aspen Highlands Skiing, 472 U.S. 585 (1985), 299
Ass’n of Am. Physicians & Surgs. v. FDA, 539 F. Supp. 2d 4 (D.D.C.
2008), 81
Associated Gen. Contractors v. Cal. State Council of Carpenters, 459
U.S. 519 (1983), 126, 127, 131
Astra USA v. Santa Clara County, 563 U.S. 110 (2011), 143
AstraZeneca AB v. Mylan Labs., 2010 U.S. Dist. LEXIS 50049
(S.D.N.Y. 2010), 311, 314
AstraZeneca Pharms. v. FDA, 850 F. Supp. 2d 230 (D.D.C. 2012), 74
Atlantic Richfield Co. v. USA Petroleum Co., 495 U.S. 328 (1990), 126
Auburn News v. Providence Journal Co., 504 F. Supp. 292 (D.R.I. 1980),
162
Avnet v. Motio, 2015 WL 5307515 (N.D. Ill. 2015), 304
B
B.A.T. Industries, 104 F.T.C. 852 (1984), 214
